Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 15;12(2):685.
doi: 10.3390/jcm12020685.

Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis

Affiliations

Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis

Eleonora Virgilio et al. J Clin Med. .

Abstract

We conducted a retrospective analysis on multiple sclerosis (MS) patients with perceived cognitive decline and long disease duration to investigate early predictors of future cognitive impairment (CI) and motor disability. Sixty-five patients complaining of cognitive decline were assessed with an extensive neuropsychological battery at the last clinical follow-up and classified as mildly impaired, severely impaired, and cognitively spared based on the results. Motor disability was assessed with EDSS, MSSS, and ARMSS. Baseline demographic, clinical, and imaging parameters were retrospectively collected and inserted in separate multivariate regression models to investigate the predictive power of future impairment. Twenty-one patients (32.3%) showed no CI, seventeen (26.2%) showed mild CI, and twenty-seven (41.5%) showed severe CI. Older and less educated patients with higher EDSS, longer disease duration, and higher white matter lesion load (WMLL) at diagnosis (particularly with cerebellar involvement) were more likely to develop CI after a mean follow-up from diagnosis of 16.5 ± 6.9 years. DMT exposure was protective. The multivariate regression analyses confirmed WMLL, disease duration, and educational levels as the parameters with significant predictive value for future CI (R2 adjusted: 0.338 p: 0.001). Older patients with progressive phenotype both at diagnosis and T1 were more likely to be not fully ambulatory at T1 (R2 adjusted: 0.796 p: 0.0001). Our results further expand knowledge on early predictors of cognitive decline and evolution over time.

Keywords: biomarkers; cognition; disability predictors; multiple sclerosis; neurodegeneration; progression.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Scott T.F. Understanding the impact of relapses in the overall course of MS; refinement of the 2 stage natural history model. J. Neuroimmunol. 2017;305:162–166. doi: 10.1016/j.jneuroim.2017.02.011. - DOI - PubMed
    1. Scalfari A., Neuhaus A., Daumer M., Muraro P.A., Ebers G.C. Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 2014;85:67–75. doi: 10.1136/jnnp-2012-304333. - DOI - PubMed
    1. Cree B.A., Gourraud P.A., Oksenberg J.R., Bevan C., Crabtree-Hartman E., Gelfand J.M., Goodin D.S., Graves J., Green A.J., Mowry E., et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann. Neurol. 2016;80:499–510. doi: 10.1002/ana.24747. - DOI - PMC - PubMed
    1. Kerbrat A., Hamonic S., Leray E., Tron I., Edan G., Yaouanq J. Ten-year prognosis in multiple sclerosis: A better outcome in relapsing-remitting patients but not in primary progressive patients. Eur. J. Neurol. 2015;22:e507–e535. doi: 10.1111/ene.12600. - DOI - PubMed
    1. Meca-Lallana V., Berenguer-Ruiz L., Carreres-Polo J., Eichau-Madueño S., Ferrer-Lozano J., Forero L., Higueras Y., Téllez Lara N., Vidal-Jordana A., Pérez-Miralles F.C. Deciphering Multiple Sclerosis Progression. Front. Neurol. 2021;12:608491. doi: 10.3389/fneur.2021.608491. - DOI - PMC - PubMed

LinkOut - more resources